Overview

Effect of Long Term Clarithromycin for Prevention of Exacerbations in Non-cystic Fibrosis Bronchiectasis in Asian Populations

Status:
Recruiting

Trial end date:
2023-09-30

Target enrollment:

Participant gender:

Summary

clarithromycin may reduce the exacerbations in middle-aged and elderly patients with non-CF bronchiectasis. The study is aimed to (A) investigate the etiologies and clinical features of patients with bronchiectasis, (B) compare the effect of clarithromycin 250mg daily on the frequency of exacerbations, quality of life and lung function, stratified according to the degree of bronchiectasis severity.

Phase:

N/A

Details

Lead Sponsor:

Chinese University of Hong Kong

Treatments:

Clarithromycin